Craneware, the US healthcare software supplier, has told investors to expect a flat financial year ahead after a disappointing FY26. Its final results, published on 21 September 2026 for the year to 30 June, combined stable revenue with weaker growth indicators, a cyber security incident and a reset of near-term expectations.
Background
Craneware sells revenue-cycle and pricing software to US hospitals. Growth in recent years has been tied partly to the 340B drug discount programme, where it expected customers to pursue so-called Shelter opportunities. According to the chair, Dr Will Whitehorn, the year did not close as anticipated because customers could not realise those opportunities and rebate licence revenue was deferred pending regulatory clarity. Chief executive Keith Neilson said FY26 was challenging and growth fell below expectations.
The figures
Revenue was $206.0m, against $205.7m the previous year. Annual recurring revenue was $185m (FY25: $184m), but net revenue retention fell to 100% from 107%. Adjusted EBITDA rose 3% to $67.1m, lifting the margin to 33%, while gross margin fell from 87% to 84%. Operating profit was $26.5m and statutory profit before tax rose 7% to $25.8m. Profit for the year was unchanged at $19.7m. Adjusted basic earnings per share were 116.8 cents (FY25: 116.1 cents).
Cash conversion was 98%, although cash generated from operations fell to $55.4m from $69.6m. Year-end cash was $54.8m. Bank debt rose to $43.5m from $27.7m, partly because a $20m drawing on the revolving credit facility helped fund a $25m share buyback, completed on 12 May 2026. The $100m facility matures in August 2028, with $56m undrawn at the year end.
Dividend
The board proposed a final dividend of 17.0p, subject to shareholder approval, down from 18.5p. The total for the year is unchanged at 32.0p. The ex-dividend date is 3 December, the record date 4 December and payment 22 December 2026.
Outlook and reset
The board has reset FY27 revenue expectations to about the level of annual recurring revenue, roughly $185m, which it calls a prudent view. It expects 340B tailwinds to build in the second half of FY27 but excludes them from revenue expectations. A review of the cost base has started, and management expects to maintain the overall EBITDA margin in the medium term. It anticipates a return to growth in FY28 and has adopted a more cautious three-year planning basis built on existing recurring revenue.
Why it matters
The update changes the equity story from growth to resilience. Recurring contracts account for 85% of revenue, and customer retention remains above 90%, which supports the base. Yet flat revenue, a retention rate of 100% and a gross margin decline suggest the company has less room for error. The higher debt after a buyback also narrows its flexibility.
Risks
The company highlights several. A cyber incident announced on 20 July 2026 involved unauthorised access and removal of files, including some employee data and a subset of customer and partner records. The company says there is no ongoing compromise or service disruption, and has informed the UK Information Commissioner's Office and the FBI. Remediation, legal, regulatory and insurance effects are not yet quantified.
Regulatory uncertainty around 340B, including a rebate pilot expected to start on 1 January 2027, continues to delay revenue recognition. Enterprise sales cycles are long. About 20% of costs are in sterling, creating some currency exposure. The board states there is no material uncertainty over going concern, but that conclusion assumes the credit facility is extended and lenders consent.






Please wait processing your request...